Adaptimmune (ADAP) Presents Data on Liver Cancer Candidate Posted byZacks Equity Research September 6, 2021 Leave a comment on Adaptimmune (ADAP) Presents Data on Liver Cancer Candidate Adaptimmune (ADAP) announces encouraging data from an early-stage study on liver cancer patients from its cell therapy candidate.